Early Treatment Response Predicts Outcome in Paediatric Ulcerative Colitis: GASTROENTEROLOGY: INFLAMMATORY BOWEL

Marco Gasparetto1,2, Vivien Wong-Spracklen2, Franco Torrente2

  • 1Department of Paediatrics, University of Cambridge, Addenbrooke's Hospital.

Insights

Predicting severe pediatric ulcerative colitis (UC) is crucial. Early identification of severe disease course in children with UC using clinical factors can guide timely interventions, potentially avoiding biologics or surgery.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Outcome Prediction

Background:

  • The disease course of pediatric ulcerative colitis (UC) is highly variable.
  • Limited data exists on predictors for disease outcomes in pediatric UC patients.

Purpose of the Study:

  • To validate clinical predictors of disease outcomes in a cohort of pediatric UC patients.
  • To identify factors associated with a severe disease course in children with UC.

Main Methods:

  • Retrospective analysis of 93 pediatric UC patients (age 2-18 years) with a minimum 18-month follow-up.
  • Stratification into mild, moderate, and severe disease course groups.
  • Statistical comparison of clinical and biochemical parameters using Chi-square, Mann-Whitney, and log-rank tests.

Main Results:

  • Predictors of a severe disease course included pancolitis, low albumin, low hemoglobin at diagnosis, high pediatric ulcerative colitis activity index (PUCAI) at 3 months, and nonresponse to steroids at 3 months.
  • Failure to achieve remission at 3 months was associated with an 80% likelihood of requiring biologics or major surgery within 18 months.

Conclusions:

  • Clinical factors at diagnosis and early disease markers (3-month assessment) are significant predictors of long-term outcomes in pediatric UC.
  • A 3-month review point is recommended to guide management decisions for children with UC, potentially altering the disease trajectory.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
527
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
577
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
663
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.9K